Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US11739095B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11739095-B2 |
| Application number | US-202117217687-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 30, 2021 |
| Priority date | Mar 31, 2020 |
| Publication date | Aug 29, 2023 |
| Grant date | Aug 29, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds having the general formula (I)wherein R1, R2, R3, R4, R5 and X are as described herein, compositions including the compounds and methods of using the compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound, wherein the compound is selected from the group consisting of: and or a pharmaceutically acceptable salt thereof. 2. A The compound according to claim 1 , wherein the compound is or a pharmaceutically acceptable salt thereof.
Ortho-condensed systems · CPC title
Drugs for disorders of the nervous system · CPC title
condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.